23andMe is one of the most well-known consumer genetic DNA testing companies focusing on health and ancestry DNA testing. Founded in 2006 by Anne Wojcicki, along with Linda Avey and Paul Cusenza, the mission of the company is to help people access, understand and benefit from the human genome. 23andMe earns most of its revenue by selling at-home DNA testing kits and selling consumer genetic databases to various healthcare organizations. The at-home genetic testing kit company went public in Jun 2021, through a merger with a Richard Branson SPAC, VG Acquisition Corp., in a deal that raised near-$600 million and valued 23andMe at $3.5 billion. Read more: https://bestpitchdeck.com/23andMe

41. 1
2
2